Insulin pharmacology classifies preparations not by chemical identity but by their pharmacokinetic profile — the triad of onset, peak, and duration of action — because these parameters determine when the drug's hypoglycemic effect will be maximal and therefore when carbohydrate intake must coincide with it. The four functional categories (rapid-acting, short-acting, intermediate-acting, and long-acting) span a continuum from immediate prandial coverage to peakless basal coverage, with the absence of a discrete peak in long-acting preparations being the defining property that makes them suitable for background rather than mealtime control. Within endocrine pharmacology, insulin represents the universal replacement therapy applicable to both absolute and relative insulin deficiency, distinguishing it from oral agents that require residual endogenous pancreatic function; its principal adverse effect, hypoglycemia, is the intended pharmacologic action carried beyond the physiologic target.
Insulin pharmacology classifies preparations not by chemical identity but by their pharmacokinetic profile — the triad of onset, peak, and duration of action — because these parameters determine when…